Skip to content
Trial Eligibility
Menu

Crownlands Observing Progression With Neurons Study

NCT07611396

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The CROWN-I Study is an observational study to learn about molecular features of Alzheimer's disease (AD) and mild cognitive impairment (MCI). The primary objective is to identify the molecular and genetic modules that differentiate patient subtypes and predict progression of AD. Participants will visit clinical sites to donate samples multiple times and perform virtual and in-person clinical assessments.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alzheimer s Disease
  • Mild Cognitive Impairment (MCI)

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
55 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Crownlands
Last updated on ClinicalTrials.gov
June 4, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • Capital Neurology · Germantown, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.